Looking from 2023 to 2024, the latest year of data available, prescriptions and gross spending for Wegovy (first approved for obesity in 2021, approved for cardiovascular disease in 2024) and Mounjaro (approved for type 2 diabetes in 2022) more than doubled, and prescriptions and gross spending for Zepbound (first approved for obesity in 2023, approved for sleep apnea in 2024) increased more than fivefold
Its one of the more silent common causes of rectal bleeding and may cause intermittent, painless bleeding
10.1080/13510002.2021.1952819 Redox Rep
, Board-Certified Emergency Medicine Physician and Co-Founder, Amanecia Health Last reviewed June 18, 2026 by Lauren Leavitt, M.D., Board-Certified Emergency Medicine Physician, Amanecia Health
Eating Shouldn't Hurt